Literature DB >> 23725859

Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC).

Pierina Navarria1, Anna Maria Ascolese, Pietro Mancosu, Filippo Alongi, Elena Clerici, Angelo Tozzi, Cristina Iftode, Giacomo Reggiori, Stefano Tomatis, Maurizio Infante, Marco Alloisio, Alberto Testori, Antonella Fogliata, Luca Cozzi, Emanuela Morenghi, Marta Scorsetti.   

Abstract

PURPOSE: To assess the impact of volumetric modulated arc therapy (VMAT) with flattening filter free (FFF) beams for stereotactic body radiotherapy (SBRT) in inoperable stage I NSCLC. Current data were compared against a cohort of patients previously treated with advanced conformal techniques (3DCRT) based on conformal arcs. METHODS AND MATERIALS: From July 2006 to December 2011 132 patients underwent SBRT, 86 by 3DCRT with flattened beams (FF), while the last 46 with VMAT RapidArc and unflattened beams (FFF). All patients were treated with 48 Gy in four fractions of 12 Gy each. Patients underwent follow-up. Clinical outcome was evaluated with thoracic and abdominal CT scan and 18FDG-CTPET before and after treatment.
RESULTS: Both techniques achieved adequate dose conformity to the target but with a statistically significant reduction of ipsilateral lung doses in RapidArc plans and also of Beam-on-Time (BOT) with FFF mode. The median follow up was 16 months (range 2-24 months). At 1 year, local control rate was 100% with FFF beams compared with 92.5% with FF beams (p=0.03).
CONCLUSIONS: SBRT with FFF beams permitted us a safe delivery of high dose per fraction in a short treatment time and resulted in an earlier radiological response compared with FF beams.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  NSCLC; SBRT; Volumetric modulated Arc Therapy

Mesh:

Year:  2013        PMID: 23725859     DOI: 10.1016/j.radonc.2013.04.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  59 in total

1.  Reirradiation of nasopharyngeal carcinoma focusing on volumetric modulated arcs with flattening filter-free beams.

Authors:  M Zhuang; L Huang; D Zhu; X Peng; Z Lin
Journal:  Br J Radiol       Date:  2015-06-02       Impact factor: 3.039

2.  Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.

Authors:  Alba Fiorentino; Niccolò Giaj-Levra; Umberto Tebano; Rosario Mazzola; Francesco Ricchetti; Sergio Fersino; Gioacchino Di Paola; Dario Aiello; Ruggero Ruggieri; Filippo Alongi
Journal:  Radiol Med       Date:  2017-04-26       Impact factor: 3.469

3.  Evaluation of a template-based algorithm for markerless lung tumour localization on single- and dual-energy kilovoltage images.

Authors:  Alec M Block; Rakesh Patel; Murat Surucu; Matthew M Harkenrider; John C Roeske
Journal:  Br J Radiol       Date:  2016-10-12       Impact factor: 3.039

4.  Effects of the recurrence pattern on patient survival following SABR for stage I lung cancer.

Authors:  Elisabeth Weiss; Xiaoyan Deng; Nitai Mukhopadhyay; Nuzhat Jan
Journal:  Acta Oncol       Date:  2020-01-12       Impact factor: 4.089

5.  Dosimetric evaluation of compensator intensity modulation-based stereotactic body radiotherapy for Stage I non-small-cell lung cancer.

Authors:  Y Tajima; H Nakayama; T Itonaga; S Shiraishi; M Okubo; R Mikami; S Sugahara; K Tokuuye
Journal:  Br J Radiol       Date:  2015-05-21       Impact factor: 3.039

6.  A surface energy spectral study on the bone heterogeneity and beam obliquity using the flattened and unflattened photon beams.

Authors:  James C L Chow; Amir M Owrangi
Journal:  Rep Pract Oncol Radiother       Date:  2015-11-30

7.  Automatically gated image-guided breath-hold IMRT is a fast, precise, and dosimetrically robust treatment for lung cancer patients.

Authors:  Anna Simeonova-Chergou; Anika Jahnke; Kerstin Siebenlist; Florian Stieler; Sabine Mai; Judit Boda-Heggemann; Frederik Wenz; Frank Lohr; Lennart Jahnke
Journal:  Strahlenther Onkol       Date:  2016-01-15       Impact factor: 3.621

8.  Optimizing the flattening filter free beam selection in RapidArc®-based stereotactic body radiotherapy for Stage I lung cancer.

Authors:  J-Y Lu; Z Lin; P-X Lin; B-T Huang
Journal:  Br J Radiol       Date:  2015-07-02       Impact factor: 3.039

9.  Towards clinical implementation of ultrafast combined kV-MV CBCT for IGRT of lung cancer : Evaluation of registration accuracy based on phantom study.

Authors:  Anna Arns; Manuel Blessing; Jens Fleckenstein; Dzmitry Stsepankou; Judit Boda-Heggemann; Anna Simeonova-Chergou; Jürgen Hesser; Frank Lohr; Frederik Wenz; Hansjörg Wertz
Journal:  Strahlenther Onkol       Date:  2016-02-10       Impact factor: 3.621

10.  Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy.

Authors:  Marta Scorsetti; Piera Navarria; Fiorenza De Rose; AnnaMaria Ascolese; Elena Clerici; Ciro Franzese; Francesca Lobefalo; Giacomo Reggiori; Pietro Mancosu; Stefano Tomatis; Antonella Fogliata; Luca Cozzi
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-17       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.